| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 57439* | 2014 |
| Heart disease and stroke statistics—2010 update: a report from the American Heart Association Writing Group Members, D Lloyd-Jones, RJ Adams, TM Brown, ... Circulation 121 (7), e46-e215, 2010 | 14193* | 2010 |
| Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial … GYH Lip, R Nieuwlaat, R Pisters, DA Lane, HJGM Crijns Chest 137 (2), 263-272, 2010 | 8109 | 2010 |
| Interventions for enhancing medication adherence R Nieuwlaat, N Wilczynski, T Navarro, N Hobson, R Jeffery, ... Cochrane database of systematic reviews, 2014 | 6411* | 2014 |
| A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey R Pisters, DA Lane, R Nieuwlaat, CB De Vos, HJGM Crijns, GYH Lip Chest 138 (5), 1093-1100, 2010 | 5604 | 2010 |
| Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation R Nieuwlaat, A Capucci, AJ Camm, SB Olsson, D Andresen, DW Davies, ... European heart journal 26 (22), 2422-2434, 2005 | 1362 | 2005 |
| American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism TL Ortel, I Neumann, W Ageno, R Beyth, NP Clark, A Cuker, BA Hutten, ... Blood advances 4 (19), 4693-4738, 2020 | 1026 | 2020 |
| Progression from paroxysmal to persistent atrial fibrillation: clinical correlates and prognosis CB De Vos, R Pisters, R Nieuwlaat, MH Prins, RG Tieleman, RJS Coelen, ... Journal of the American College of Cardiology 55 (8), 725-731, 2010 | 900 | 2010 |
| American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients HJ Schünemann, M Cushman, AE Burnett, SR Kahn, J Beyer-Westendorf, ... Blood advances 2 (22), 3198-3225, 2018 | 761 | 2018 |
| Living systematic review: 1. Introduction—the why, what, when, and how JH Elliott, A Synnot, T Turner, M Simmonds, EA Akl, S McDonald, ... Journal of clinical epidemiology 91, 23-30, 2017 | 606 | 2017 |
| American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy DM Witt, R Nieuwlaat, NP Clark, J Ansell, A Holbrook, J Skov, N Shehab, ... Blood advances 2 (22), 3257-3291, 2018 | 530 | 2018 |
| Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies R Khatib, JD Schwalm, S Yusuf, RB Haynes, M McKee, M Khan, ... PloS one 9 (1), e84238, 2014 | 530 | 2014 |
| Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials PS Roshanov, N Fernandes, JM Wilczynski, BJ Hemens, JJ You, ... Bmj 346, 2013 | 514 | 2013 |
| Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation R Nieuwlaat, A Capucci, GYH Lip, SB Olsson, MH Prins, FH Nieman, ... European heart journal 27 (24), 3018-3026, 2006 | 512 | 2006 |
| Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation N Dagres, R Nieuwlaat, PE Vardas, D Andresen, S Lévy, S Cobbe, ... Journal of the American College of Cardiology 49 (5), 572-577, 2007 | 490 | 2007 |
| American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 A Cuker, EK Tseng, R Nieuwlaat, P Angchaisuksiri, C Blair, K Dane, ... Blood advances 5 (3), 872-888, 2021 | 465 | 2021 |
| Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation R Nieuwlaat, MH Prins, JY Le Heuzey, PE Vardas, E Aliot, M Santini, ... European heart journal 29 (9), 1181-1189, 2008 | 386 | 2008 |
| Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation A Ringborg, R Nieuwlaat, P Lindgren, B Jönsson, D Fidan, AP Maggioni, ... Europace 10 (4), 403-411, 2008 | 335 | 2008 |
| Living systematic reviews: 2. Combining human and machine effort J Thomas, A Noel-Storr, I Marshall, B Wallace, S McDonald, ... Journal of clinical epidemiology 91, 31-37, 2017 | 324 | 2017 |
| Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart … R Nieuwlaat, SB Olsson, GYH Lip, AJ Camm, G Breithardt, A Capucci, ... American heart journal 153 (6), 1006-1012, 2007 | 278 | 2007 |